Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|March 26, 2022
Covalent Attachment of Aggregation-Induced Emission Molecules to the Surface of Ultrasmall Gold Nanoparticles to Enhance Cell PenetrationKai Klein, Matthias Hayduk, Sebastian Kollenda, et al.
Macromolecular Rapid Communications|July 3, 2020
pH-Controlled Hierarchical Assembly/Disassembly of Multicompartment Micelles in WaterTai-Lam Nghiem, Ramzi Chakroun, Nicole Janoszka, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 12, 2023
Absorption, Distribution, Metabolism, and Excretion of [<sup>14</sup>C]iptacopan in Healthy Male Volunteers and in In Vivo and In Vitro StudiesAlexander David James, Kenneth Kulmatycki, Birk Poller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 9, 2017
Midostaurin, a Novel Protein Kinase Inhibitor for the Treatment of Acute Myelogenous Leukemia: Insights from Human Absorption, Metabolism, and Excretion Studies of a BDDCS II DrugHandan He, Phi Tran, Helen Gu, et al.
Nanoscale Advances|November 7, 2022
Silencing of proinflammatory NF-κB and inhibition of herpes simplex virus (HSV) replication by ultrasmall gold nanoparticles (2 nm) conjugated with small-interfering RNANatalie Wolff, Sebastian Kollenda, Kai Klein, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 17, 2022
Uptake of Functional Ultrasmall Gold Nanoparticles in 3D Gut Cell ModelsViktoriya Sokolova, Jana-Fabienne Ebel, Sebastian Kollenda, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 27, 2025
A Modular Solid Phase Synthesis Approach for Glycocalix[4]Arene Derivatives and Their Multivalent Presentation on Ultrasmall Gold NanoparticlesAlisa Kayser, Kai Klein, Daria Babushkina, et al.
Journal of Medicinal Chemistry|March 13, 2024
Structure-Guided Elaboration of a Fragment-Like Hit into an Orally Efficacious Leukotriene A4 Hydrolase InhibitorGebhard Thoma, Wolfgang Miltz, Honnappa Srinivas, et al.
Clinical and Translational Science|February 26, 2024
LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trialChristian Loesche, Damien Picard, Benjamin Van Hoorick, et al.
Biomacromolecules|July 28, 2023
Potentiating Tweezer Affinity to a Protein Interface with Sequence-Defined Macromolecules on NanoparticlesTheresa Seiler, Annika Lennartz, Kai Klein, et al.
Pageof 2